Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2021 Jul-Aug;15(4):102196.
doi: 10.1016/j.dsx.2021.102196. Epub 2021 Jul 3.

Diabetes, COVID 19 and mucormycosis: Clinical spectrum and outcome in a tertiary care medical center in Western India

Affiliations
Clinical Trial

Diabetes, COVID 19 and mucormycosis: Clinical spectrum and outcome in a tertiary care medical center in Western India

Yogendra Mishra et al. Diabetes Metab Syndr. 2021 Jul-Aug.

Abstract

Aims: Diabetes Mellitus predisposes patients to invasive fungal infections. There has been a recent surge of Mucormycosis with COVID 19 infection particularly in patients with diabetes. This study aims to study the clinical spectrum of CAM (COVID -associated Mucormycosis) with diabetes and subsequent outcomes.

Material and methods: This was a descriptive study conducted at a single COVID Care Centre in India in patients with COVID Associated Mucormycosis from April 12, 2021 to May 31, 2021.

Results: Among 953 hospitalized patients with COVID 19 infection, 32 patients had CAM with an incidence of 3.36%. In patients with CAM, 87.5% had Diabetes Mellitus as the most common co-morbidity. The majority of the patients had poor glycemic control with a mean HbA1c of 9.06%. Out of the total study population, 93% had prior exposure to high dose corticosteroids. During the study period, 12.5% patients of CAM did not survive.

Conclusion: Mucormycosis is an angioinvasive fungal infection with high mortality. The disease has surged in COVID 19 pandemic due to uncontrolled diabetes and improper corticosteroid use.

Keywords: COVID-19; Diabetes; Mucormycosis.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The Authors declare there is no conflict of interest.

Figures

Fig. 1
Fig. 1
Box and whisker plot showing relationship of total leucocyte count with outcome in patients with Covid-Associated Mucormycosis.
Fig. 2
Fig. 2
Clinical spectrum of Covid -Associated Mucormycosis (A) Right Orbital cellulitis (B) Palatal Mucormycosis (C) Cutaneous Mucormycosis involving face in our patients.
Fig. 3
Fig. 3
Radiological images of Rhino-orbital Mucormycosis (A) MRI Orbit suggestive of right orbital involvement. (B&C) Commuted Tomography of Paranasal sinuses suggestive of right maxillary sinusitis.
Fig. 4
Fig. 4
Histopathology of post-operation specimen with Hematoxylin &Eosin staining showing(A) Broad branched aseptate fungal hyphae suggestive of Mucormycosis (B) Fungal invasion into the vessel wall.

References

    1. Dong E., Du H., Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020 May;20(5):533–534. - PMC - PubMed
    1. Armstrong-James D., Youngs J., Bicanic T., Abdolrasouli A., Denning D.W., Johnson E., et al. Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosis. Eur Respir J. 2020 Oct;56(4) - PMC - PubMed
    1. Nucci M., Barreiros G., Guimarães L.F., Deriquehem V.A.S., Castiñeiras A.C., Nouér S.A. Increased incidence of candidemia in a tertiary care hospital with the COVID-19 pandemic. Mycoses. 2021 Feb;64(2):152–156. - PMC - PubMed
    1. Raut A., Huy N.T. Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave? Lancet Respir Med. 2021 Jun doi: 10.1016/S2213-2600(21)00265-4. - DOI - PMC - PubMed
    1. Ibrahim A.S., Spellberg B., Walsh T.J., Kontoyiannis D.P. Pathogenesis of mucormycosis. Clin Infect Dis. 2012 Feb 1;54(suppl_1):S16–S22. - PMC - PubMed

Publication types